Skip to Content

J 35 (Tenofovir Disoproxil Fumarate 150 mg)

Pill with imprint J 35 is White, Capsule-shape and has been identified as Tenofovir Disoproxil Fumarate 150 mg. It is supplied by Aurobindo Pharma Limited.

Tenofovir is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for J 35

Tenofovir Disoproxil Fumarate

Imprint
J 35
Strength
150 mg
Color
White
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
65862-0818
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch, hypromellose 2910 (15 mPa.s), titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "J 35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.